Analytical performance of thrombospondin-1 and cathepsin D immunoassays part of a novel CE-IVD marked test as an aid in the diagnosis of prostate cancer.
The Prostate Specific Antigen (PSA) test suffers from low specificity for the diagnosis of Prostate Cancer (PCa). We originally discovered two cancer-related proteins thrombospondin-1 (THBS1) and cathepsin D (CTSD) using a mass-spectrometry-based proteomics approach. The two serum proteins were show...
Main Authors: | Annalisa Macagno, Alcibiade Athanasiou, Anja Wittig, Ramy Huber, Stephan Weber, Thomas Keller, Martin Rhiel, Bruno Golding, Ralph Schiess |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0233442 |
Similar Items
-
Development and clinical testing of individual immunoassays for the quantification of serum glycoproteins to diagnose prostate cancer.
by: Kathrin Endt, et al.
Published: (2017-01-01) -
Toward Patient Specific Models of Pediatric IVDs: A Parametric Study of IVD Mechanical Properties
by: Edmund Pickering, et al.
Published: (2021-02-01) -
The development of immunoassays for ubiquitin, leucocyte elastase and cathepsin G
by: Mitchell, S. H.
Published: (1985) -
Collision study for the one-way IVDS channel
by: Harmon, Andrew James
Published: (2014) -
Epigenetic IVD Tests for Personalized Precision Medicine in Cancer
by: Jesús Beltrán-García, et al.
Published: (2019-06-01)